JILL FRITZ: Open Payments
NPI 1720146947 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 54 payments from 20 companies in 2025. Trend: 2023 $671 · 2024 $1,101 · 2025 $1,167
Food & beverage: $1,098Education: $69
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $189 |
| Regeneron Healthcare Solutions, Inc. | 4 | $116 |
| JAZZ PHARMACEUTICALS INC. | 3 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94 |
| Viatris Specialty LLC | 5 | $84 |
| Grifols USA, LLC | 4 | $80 |
| United Therapeutics Corporation | 3 | $75 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Genentech USA, Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $49 |
Products named: DUPIXENT, XYWAV, FASENRA, YUPELRI, Prolastin-C Liquid, TEZSPIRE, Xolair, NUCALA.
Industry payments across MO — which companies pay providers there.
